Connexion
E-mail
Mot de passe
Afficher le mot de passe
Retenir
Mot de passe oublié ?
Devenir membre gratuitement
Inscription
Inscription
Devenir membre
Inscription gratuite
Devenir client
Découvrez nos services
Paramètres
Paramètres
Cotations dynamiques 
OFFON

ASCENDIS PHARMA A/S

(ASND)
  Rapport
SynthèseCotationsGraphiquesActualitésNotationsAgendaSociétéFinancesConsensusRévisionsDérivésFondsCommunauté 
SynthèseToute l'actualitéReco analystesAutres languesCommuniquésPublications officiellesActualités du secteur
Actualités dans d'autres langues sur ASCENDIS PHARMA A/S
17/10Certain Ordinary Shares of Ascendis Pharma A/S are subject to a Lock-Up Agreement Endin..
17/10Certain Warrants of Ascendis Pharma A/S are subject to a Lock-Up Agreement Ending on 1..
15/10U.S. Supreme Court refuses stay request for Spire Missouri natgas pipe
15/10Health Care Stocks Climb Pre-Bell Friday
15/10ASCENDIS PHARMA A/S : Health Care
15/10ASCENDIS PHARMA A/S : INCORPORATION BY REFERENCE - Form 6-K
15/10ASCENDIS PHARMA A/S : Begins US Commercial Launch of Pediatric Growth Hormone Deficiency T..
15/10ASCENDIS PHARMA A/S : Announces U.S. Commercial Launch of SKYTROFA® (Lonapegsomatropin-tcg..
15/10Ascendis Pharma A/S Announces U.S. Commercial Launch of Skytrofa the First and Only FDA..
06/10European ADRs Move Lower in Wednesday Trading
01/10ASCENDIS PHARMA A/S : Articles of Association (Form 6-K)
30/09ASCENDIS PHARMA A/S : A/S Announces Presentations for TransCon™ PTH and TransCon&tra..
30/09Ascendis Pharma A/S Announces Presentations for TransCon PTH and TransCon CNP at the Am..
29/09ASCENDIS PHARMA A/S : to Buy Back Up to $25 Million in American Depositary Shares by Year-..
29/09ASCENDIS PHARMA A/S : Announces Share Repurchase Program
29/09Ascendis Pharma A/S announces an Equity Buyback for 300,000 shares, for $25 million.
29/09Ascendis Pharma A/S authorizes a Buyback Plan.
27/09PRIME MINING : Appoints New Board Member and Exploration Executive, Provides Update
23/09European ADRs Move Sharply Higher in Thursday Trading
22/09ASCENDIS PHARMA A/S : INCORPORATION BY REFERENCE (Form 6-K)
22/09Ascendis Pharma A/S Announces Mean Bone Mineral Density (BMD) Data from Phase 2 PaTH Fo..
22/09Ascendis Pharma A/S Announces Mean Bone Mineral Density Data from Phase 2 PaTH Forward ..
16/09ASCENDIS PHARMA A/S : Articles of Association (Form 6-K)
07/09ASCENDIS PHARMA A/S : Seeks FDA Nod to Start TransCon Trial in Patients with Advanced Canc..
07/09Ascendis Pharma A/S Announces Upcoming Investor Presentations
07/09Ascendis Pharma A/S Submits Investigational New Drug Application to Initiate TransCon&t..
07/09Ascendis Pharma A/S Submits Investigational New Drug Application to Initiate TransCon™ ..
07/09European ADRs Move Lower in Tuesday Trading
02/09European ADRs Move Higher in Thursday Trading
02/09ASCENDIS PHARMA A/S : Prices Offering at $160 Per ADS
02/09Ascendis Pharma A/S Announces Pricing of Public Offering of ADSs
01/09Health Care Stocks Reverse Losses as Biotechs Rise
01/09ADRs End Mostly Higher, Ascendis Pharma Trades Actively
01/09Health Care Stocks Edging Lower, Biotechs Working to Limit Declines
01/09Health Care Stocks Inch Higher Ahead of Wednesday Open
31/08ASCENDIS PHARMA A/S : Launches Share Offering -- Stock Down 4% After-Hours
31/08Ascendis Pharma A/S Announces Proposed Public Offering of ADSs
27/08ASCENDIS PHARMA A/S : Unaudited Condensed Consolidated Interim Statements of Profit or Los..
27/08European ADRs Rise Nearly 1% Friday Morning
27/08ASCENDIS PHARMA A/S : INCORPORATION BY REFERENCE (Form 6-K)
27/08ASCENDIS PHARMA A/S : Reports Second Quarter 2021 Financial Results (Form 6-K)
26/08AFTER HOURS WATCH LIST SCORECARD : Asnd, zuo, slqt,
26/08SECTOR UPDATE : Health Care Stocks Ending Slightly Lower This Afternoon
26/08SECTOR UPDATE : Health Care Stocks Pare Early Declines
26/08Ascendis Pharma Shares Up About 25% After FDA Approval of Skytrofa
26/08European ADRs Move Lower in Thursday Trading
26/08Wall Street Treads Water Pre-Bell, Q2 GDP Growth Upwardly Revised to 6.6%
26/08SECTOR UPDATE : Health Care Stocks Mixed Pre-Bell Thursday
26/08US Futures Quiet Ahead of GDP Data
26/08UPDATE : Ascendis Pharma Q2 Loss Widens as Sales Drop; Shares Rise Pre-Market on FDA Nod f..
25/08MT NEWSWIRES AFTER HOURS WATCH LIST : Asnd, zuo, slqt
25/08ASCENDIS PHARMA A/S : Q2 Loss Widens, Revenue Declines; Wins FDA Approval for Growth Hormo..
25/08ASCENDIS PHARMA A/S : Q2 Earnings and Skytrofa® FDA Approval Call
25/08Ascendis Pharma A/S Reports Second Quarter 2021 Financial Results
25/08Ascendis Pharma A/S Reports Earnings Results for the Second Quarter Ended June 30, 2021
25/08Ascendis Pharma A/S Announces U.S. Food and Drug Administration Approval of SKYTROFA® (..
25/08Ascendis Pharma Announces U.S. Food and Drug Administration Approval of SKYTROFA
25/08ASCENDIS PHARMA : FDA Approves Skytrofa to Treat Pediatric Growth Hormone Deficiency
25/08ASCENDIS PHARMA A/S : Trading in Ascendis Pharma Shares Halted Pending News Release
17/08Ascendis Pharma A/S Announces Second Quarter 2021 Financial Results and Business Update..
12/08ASCENDIS PHARMA A/S : Articles of Association (Form 6-K)
06/08ASCENDIS PHARMA A/S : Announces Upcoming Investor Presentations in August
03/08European ADRs Move Higher in Tuesday Trading
16/07PAYCOM SOFTWARE : Insider Selling in Paycom Software (PAYC) Shares Continues
15/07ASCENDIS PHARMA A/S : Articles of Association (Form 6-K)
14/07INSIDER TRENDS : Insider 90-Day Selling Trend Prolonged at Paycom Software
06/07ASCENDIS PHARMA A/S : Hits Target Enrollment Target for Phase Trial of TransCon PTH
06/07ASCENDIS PHARMA A/S : INCORPORATION BY REFERENCE (Form 6-K)
06/07ASCENDIS PHARMA A/S : Announces Target Enrollment Achieved in the Phase 3 PaTHway Trial of..
06/07Ascendis Pharma A/S Announces Target Enrollment Achieved in the Phase 3 PaTHway Trial o..
29/06European ADRs Move Lower in Tuesday Trading
14/06European ADRs Move Higher in Monday Trading
14/06Ascendis Pharma A/S Appoints Birgitte Volck as the Senior Vice President & Head of Clin..
14/06Ascendis Pharma A/S Announces U.S. Food and Drug Administration Notifies Information Su..
14/06ASCENDIS PHARMA A/S : INCORPORATION BY REFERENCE (Form 6-K)
1  2  3  4  5  6Suiv.
Prochain événement sur ASCENDIS PHARMA A/S